Cargando…
Understanding and managing atherosclerotic renovascular disease: still a work in progress
Atherosclerotic renovascular disease (ARVD) is an unresolved therapeutic dilemma despite extensive pre-clinical and clinical studies. The pathophysiology of the disease has been widely studied, and many factors that may be involved in progressive renal injury and cardiovascular risk associated with...
Autor principal: | Chade, Alejandro R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281014/ https://www.ncbi.nlm.nih.gov/pubmed/30631430 http://dx.doi.org/10.12688/f1000research.16369.1 |
Ejemplares similares
-
Approach to atherosclerotic renovascular disease: 2016
por: Daloul, Reem, et al.
Publicado: (2016) -
Atherosclerotic renovascular disease – epidemiology, treatment and current challenges
por: Vassallo, Diana, et al.
Publicado: (2017) -
Disparate effects of single endothelin A and B receptor blocker therapy on the progression of renal injury in advanced renovascular disease
por: Chade, Alejandro R., et al.
Publicado: (2013) -
Endovascular treatments of atherosclerotic renovascular disease: a narrative review and literature search
por: Yeşiltaş, Mehmet Ali, et al.
Publicado: (2023) -
Atherosclerotic Renovascular Hypertension : Lessons from Recent Clinical Studies
por: Chung, Wookyung, et al.
Publicado: (2010)